Search Results 611-620 of 16381 for Ureaplasma urealyticum

  1. A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors - Mayo Clinic

    Patient has an active infection requiring IV systemic therapy. Patient has known hypersensitivity to any components of any study drug or any of its ...

  2. A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus - Mayo Clinic

    * Known active infection, or any major episode of infection requiring hospitalization or treatment with parenteral (intramuscular or IV) antimicrobial ...

  3. Artificial Intelligence Assistant in Managing Uncomplicated Urinary Tract Infections in Women - Mayo Clinic

    Patient has a documented kidney infection in the past 3 months, reports history of kidney stones in the past 12 months, history of renal transplant or ...

  4. Neobladder reconstruction - Mayo Clinic

    Infection; Urine leaks; Urine retention; Electrolyte imbalances; Vitamin B-12 deficiency; Loss of bladder control (incontinence); Cancer of the intestine. How ...

  5. Treatment of Heavy Menstrual Bleeding in Women With Uterine Fibroids - Mayo Clinic

    Pelvic inflammatory disease or infection with gonorrhea or chlamydia in last 3 months. Hemoglobin less than 8mg/dL; for women 8-12 mg/dL recommend iron ...

  6. Mayo Clinic Graduate School of Biomedical Sciences PhD Program - Immunology Track.

  7. Digestive Diseases Clinical Trials - Medical Professionals

    The purpose of this study is to evaluate the effects of improving glycemic control, and/or reducing glycemic variability on gastric emptying, ...

  8. Ustekinumab-auub (intravenous route, subcutaneous route) - Mayo Clinic

    Tuberculosis infection, inactive—Should be treated first before starting therapy with this medicine. Back to top. Proper Use.

  9. Eculizumab-aeeb (intravenous route) - Mayo Clinic

    Other Medical Problems · Infection or · Neutropenia (low white blood cells) or · Weak immune system—Use with caution. May increase risk of serious infections.

  10. A Study of Nivolumab and Multi-fraction Stereotactic Radiosurgery with or without Ipilimumab in Treating Participants with Recurrent Grade II-III Meningioma - Mayo Clinic

    Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris ...